TABLE 1.

Comparison of Whole-Body Distribution After Intravenous Administration of ²¹¹At Solutions Between AA(−) Group and AA(+) Group

Site	AA(−)	AA(+)	P
Brain	0.03 ± 0.02	0.02 ± 0.00	0.89
Thyroid	61.7 ± 16.2	417.6 ± 108.3	0.03*
Submandibular gland	0.20 ± 0.01	0.17 ± 0.02	0.44
Heart	0.24 ± 0.02	0.24 ± 0.03	0.25
Lung	0.78 ± 0.18	0.84 ± 0.05	0.28
Thymus	0.20 ± 0.02	0.35 ± 0.06	0.02*
Liver	0.21 ± 0.07	0.11 ± 0.00	0.75
Stomach	3.36 ± 1.16	3.56 ± 0.15	0.18
Small intestine	0.31 ± 0.06	0.30 ± 0.02	0.25
Large intestine	0.29 ± 0.01	0.56 ± 0.13	0.15
Cecum	0.36 ± 0.05	0.41 ± 0.08	0.14
Kidney	0.33 ± 0.03	0.29 ± 0.02	0.40
Adrenal gland	0.19 ± 0.04	0.13 ± 0.01	0.45
Pancreas	0.15 ± 0.01	0.13 ± 0.05	0.55
Spleen	1.13 ± 0.22	1.36 ± 0.28	0.14
Testis	0.35 ± 0.01	0.35 ± 0.02	0.25
Blood	0.12 ± 0.02	0.13 ± 0.00	0.24

^*Statistically significant.

Data are mean (±SE) percentage injected dose per gram.